ANGIOTENSIN TYPE-1 RECEPTOR AND ACE2 AUTOANTIBODIES IN PARKINSON´S DISEASE

ANGIOTENSIN TYPE-1 RECEPTOR AND ACE2 AUTOANTIBODIES IN PARKINSON´S DISEASE

Show other versions (1)

Bibliographic Details
Main Authors:	Ana Isabel Rodríguez Pérez, Carmen M Labandeira, María A Pedrosa, Aloia Quijano, Rita Valenzuela, Pablo Garrido-Gil, Mariña Sanchez-Andrade, Juan Antonio Suárez-Quintanilla, José Luis Labandeira-García
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123010114

Similar Items

Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
by: Carmen M. Labandeira, et al.
Published: (2022-06-01)

AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.
by: Ana Isabel Rodríguez Pérez, et al.
Published: (2023-10-01)

Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
by: Jose L. Labandeira-Garcia, et al.
Published: (2022-02-01)

Extracellular Vesicles and Their Renin–Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson’s Disease
by: Maria A. Pedrosa, et al.
Published: (2023-11-01)

The role of the brain renin-angiotensin system in Parkinson´s disease
by: Jose Luis Labandeira-Garcia, et al.
Published: (2024-04-01)

THE ANGIOTENSIN TYPE 2 RECEPTOR GENE MEDIATES SEXUAL DIMORPHISM IN MICROGLIAL INFLAMMATORY RESPONSES
by: Pablo Garrido-Gil, et al.
Published: (2023-10-01)

THE ANGIOTENSIN-TYPE-2 RECEPTORS ARE INVOLVED IN AGE-RELATED CHANGES AND NEUROINFLAMMATION IN THE SUBSTANTIA NIGRA
by: Pablo Garrido-Gil, et al.
Published: (2023-10-01)

Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease
by: Garrido-Gil Pablo, et al.
Published: (2012-02-01)

Renin angiotensin system and gender differences in dopaminergic degeneration
by: Rodriguez-Perez Ana I, et al.
Published: (2011-08-01)

DOPAMINE INCREASE ADULT NEUROGENESIS IN THE VENTRICULAR-SUBVENTRICULAR ZONE VIA DOPAMINE D3 RECEPTORS AND RECIPROCAL INTERACTIONS WITH ANGIOTENSIN TYPE 2 RECEPTOR.
by: Juan Parga, et al.
Published: (2023-10-01)

Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the <i>Substantia Nigra</i> of Male Rodents and Primary Mesencephalic Cultures
by: Aloia Quijano, et al.
Published: (2022-02-01)

An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria
by: Rita Valenzuela, et al.
Published: (2021-10-01)

Brain renin-angiotensin system and dopaminergic cell vulnerability
by: Jose L Labandeira-Garcia, et al.
Published: (2014-07-01)

Angiotensin AT1 and AT2 receptor heteromer expression in the hemilesioned rat model of Parkinson’s disease that increases with levodopa-induced dyskinesia
by: Rafael Rivas-Santisteban, et al.
Published: (2020-08-01)

NRF2 Activation and Downstream Effects: Focus on Parkinson’s Disease and Brain Angiotensin
by: Juan A. Parga, et al.
Published: (2021-10-01)

Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration
by: Jose L. Labandeira-Garcia, et al.
Published: (2017-05-01)

ACE inhibitors, angiotensin receptor antagonists and bradykinin
by: Michael Schachter
Published: (2000-03-01)

Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA
by: Ana Muñoz, et al.
Published: (2020-06-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

Association of Angiotensin Receptor Autoantibodies With Cardiovascular Abnormalities in Preeclampsia
by: Anum S. Minhas, et al.
Published: (2021-06-01)

NADPH-Oxidase, Rho-Kinase and Autophagy Mediate the (Pro)renin-Induced Pro-Inflammatory Microglial Response and Enhancement of Dopaminergic Neuron Death
by: Andrea Lopez-Lopez, et al.
Published: (2021-08-01)

Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia
by: Andrea Lopez-Lopez, et al.
Published: (2023-07-01)

Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue
by: Rafael Franco, et al.
Published: (2020-12-01)

Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission
by: Lucia Lage, et al.
Published: (2024-02-01)

Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors
by: Begoña Villar-Cheda, et al.
Published: (2012-08-01)

Ecology and Evolution of Gall-Inducing Arthropods: The Pattern From the Terrestrial Fossil Record
by: Conrad C. Labandeira, et al.
Published: (2021-06-01)

Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome
by: Xichun Yu, et al.
Published: (2018-04-01)

Interaction of -blockers and angiotensin receptor blockers/ACE inhibitors in heart failure
by: Jay N Cohn
Published: (2003-09-01)

Novel Interactions between Mas and Angiotensin Receptors and Their Functionality Modulatory Role for the Brain RAS
by: Rafael Rivas-Santisteban, et al.
Published: (2021-07-01)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
by: Ahmed Daoud, et al.
Published: (2021-01-01)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
by: Ikram Omar Osman, et al.
Published: (2021-06-01)

Review: Effect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease
by: Trefor Morgan
Published: (2001-03-01)

Comparing recommended doses of angiotensin receptor blockers and ACE inhibitors (CORD Study)
by: J. Spinar, et al.
Published: (2009-08-01)

The four phases of plant-arthropod associations in deep time
by: C. LABANDEIRA
Published: (2006-01-01)

Elevated Transglutaminase Activity Triggers Angiotensin Receptor Activating Autoantibody Production and Pathophysiology of Preeclampsia
by: Chen Liu, et al.
Published: (2015-12-01)

Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling.
by: Nicola E Clarke, et al.
Published: (2012-01-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses
by: Julián Segura, et al.
Published: (2003-03-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2022-12-01)

The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
by: Juanjuan Xu, et al.
Published: (2017-05-01)